Icon

AYVAKIT (nda212608)- (25MG,50MG,100MG,200MG,300MG)

AVAPRITINIB BLUEPRINT MEDICINES
25MG,50MG,100MG,200MG,300MG
No No
2042-Mar-08 2025-Jan-09
None None
None No
AYVAKIT is a kinase inhibitor indicated for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations.
0 0 0
Total Other Developers None
Drugs with Suitability No
25MG ** ** - - -
50MG ** ** - - -
100MG ** ** - - -
200MG ** ** - - -
300MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.